Tissue factor: a novel therapeutic target against breast cancer stem cells

被引：0
|
作者：
Shaker, H. [1 ,2 ]
Harrison, H. [1 ]
Clarke, R. [3 ]
Landberg, G. [1 ]
Bundred, N. J. [2 ]
Versteeg, H. H. [4 ]
Kirwan, C. C. [2 ]
机构：
[1] Canc Res UK Manchester Inst, Breakthrough Breast Canc Unit, Manchester, Lancs, England
[2] Univ Manchester, Manchester Acad Hlth Sci Ctr, Univ S Manchester Hosp, Acad Dept Surg, Manchester, Lancs, England
[3] Canc Res UK Manchester Inst, Breast Biol Grp, Manchester, Lancs, England
[4] Einthoven Lab Expt Vasc Med, Dept Thrombosis & Hemostasis, Leiden, Netherlands
来源：
THROMBOSIS RESEARCH | 2014年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S200 / S200
页数：1
相关论文
共 50 条
  • [21] Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
    Ajmeera, Divya
    Ajumeera, Rajanna
    GENES & DISEASES, 2024, 11 (01) : 148 - 175
  • [22] NFATC2 is a novel therapeutic target for colorectal cancer stem cells
    Lang, Tingyuan
    Ding, Xiaojuan
    Kong, Liangsheng
    Zhou, Xiaoyan
    Zhang, Zhiqi
    Ju, Huangxian
    Ding, Shijia
    ONCOTARGETS AND THERAPY, 2018, 11 : 6911 - 6924
  • [23] EMP2 is a novel therapeutic target for endometrial cancer stem cells
    M H Kiyohara
    C Dillard
    J Tsui
    S R Kim
    J Lu
    D Sachdev
    L Goodglick
    M Tong
    V F Torous
    C Aryasomayajula
    W Wang
    P Najafzadeh
    L K Gordon
    J Braun
    S McDermott
    M S Wicha
    M Wadehra
    Oncogene, 2017, 36 : 5793 - 5807
  • [24] EMP2 is a novel therapeutic target for endometrial cancer stem cells
    Kiyohara, M. H.
    Dillard, C.
    Tsui, J.
    Kim, S. R.
    Lu, J.
    Sachdev, D.
    Goodglick, L.
    Tong, M.
    Torous, V. F.
    Aryasomayajula, C.
    Wang, W.
    Najafzadeh, P.
    Gordon, L. K.
    Braun, J.
    McDermott, S.
    Wicha, M. S.
    Wadehra, M.
    ONCOGENE, 2017, 36 (42) : 5793 - 5807
  • [25] O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells
    Cheng, Jing-Yan
    Hung, Jung-Tung
    Lin, Juway
    Lo, Fei-Yun
    Huang, Jing-Rong
    Chiou, Shih-Pin
    Wang, Ya-Hui
    Lin, Ruey-Jen
    Wu, Jen-Chine
    Yu, John
    Yu, Alice L.
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [26] Stem like cells in human breast cancer: EP4 as a therapeutic target
    Majumder, Mousumi
    Xin, Xiping
    Liu, Ling
    Bell, Gillian
    Landman, Erin
    Rodriguez-Torres, Mauricio
    Postovit, Lynne-Marie
    Hess, David
    Lala, Peeyush K.
    CANCER RESEARCH, 2014, 74 (19)
  • [27] Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target
    Ginestier, Christophe
    Monville, Florence
    Wicinski, Julien
    Cabaud, Olivier
    Cervera, Nathalie
    Josselin, Emmanuelle
    Finetti, Pascal
    Guille, Arnaud
    Larderet, Gaelle
    Viens, Patrice
    Sebti, Said
    Bertucci, Francois
    Birnbaum, Daniel
    Charafe-Jauffret, Emmanuelle
    STEM CELLS, 2012, 30 (07) : 1327 - 1337
  • [28] Macrophage migration inhibitory factor (MIF): A novel therapeutic target against aggressive cancer
    Das, Subhadip
    Chatterjee, Nabanita
    Ahirwar, Dinesh K.
    Mishra, Sanjay
    Varikuti, Sanjay
    Kaul, Kirti
    Satoskar, Abhay R.
    Ganju, Ramesh K.
    FASEB JOURNAL, 2019, 33
  • [29] Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia
    Chen, Yaoyu
    Peng, Cong
    Sullivan, Con
    Li, Dongguang
    Li, Shaoguang
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2010, 10 (02) : 111 - 115
  • [30] Stem cells and breast cancer: treatment resistance, markers and novel therapeutic targets
    Clarke, R.
    EJC SUPPLEMENTS, 2009, 7 (04): : 2 - 2
12345